Mr. Michael W Border, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 20 Southbridge Rd, Charlton, MA 01507 Phone: 508-765-9068 Fax: 508-765-0249 |
Dr. Sara A Mahony, MD, PHARMD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 20 Southbridge Rd, Charlton, MA 01507 Phone: 508-765-9068 Fax: 508-765-0249 |
News Archive
Ornaments glistening on a pine tree, carols filling the air, shoppers scurrying through stores and the smell of goodies baking in the oven—it's the holidays. For many this truly is the most wonderful time of the year. Still, for those who have lost a loved one, the empty chair at the table or one less present under the tree can be a painful reminder of the one who is missing.
Previous studies have shown that many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases were tied to asymptomatic carriers or those who do not manifest symptoms of the viral infection. Now, a new study reveals that in the first Italian town hit by the virus, as much as 40 percent of the population had no symptoms of the coronavirus disease (COVID-19).
A selection of health policy stories from New York, Florida, California and Oregon.
The U.S. Food and Drug Administration today expanded the approval of the MiniMed 670G hybrid closed looped system, a diabetes management device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses with little or no input from the user, to include individuals aged 7 to 13 with type 1 diabetes.
Rice University bioengineers and physician-scientists at Baylor College of Medicine and Texas Children's Hospital have successfully destroyed tumors of human brain cancer cells in the first animal tests of a minimally invasive treatment that zaps glioma tumors with heat. The tests involved nanoshells, light-activated nanoparticles that are designed to destroy tumors with heat and avoid the unwanted side effects of drug and radiation therapies.
› Verified 2 days ago